Resolution of sirolimus-induced pneumonitis after conversion to everolimus

Transplantation Proceedings
B RehmS Stracke

Abstract

Sirolimus-induced pneumonitis usually requires the complete cessation of sirolimus. Herein we have reported five cases of recovery from sirolimus pneumonitis after conversion from sirolimus to everolimus. All five cases were comparable with regard to their clinical conditions. The ages were between 46 and 64 years. They had received kidney transplants 3 to 18 years earlier. In four cases, the reason for sirolimus therapy was toxicity due to calcineurin inhibitors on a transplant biopsy; three of the patients also displayed malignant tumors: renal cell carcinoma, spinocellular carcinoma, or melanoma. Their serum creatinine levels were elevated between 150 and 350 micromol/L. In all five cases, bronchoscopy disclosed lymphocytic pneumonitis and bronchiolitis obliterans. The immunosuppressive co-medications were prednisolone in three, azathioprine in one, and mycophenolate mofetil in four cases. The previous sirolimus dose was 1 to 4 mg/day, with sirolimus trough levels between 5 and 12 ng/mL. The patients were switched to everolimus at doses between 1 x 0.25 and 2 x 0.75 mg/day to achieve trough concentrations between 3 and 8 ng/mL. Pulmonary symptoms and radiological findings resolved completely within 1 to 4 weeks. Everolimus i...Continue Reading

References

Apr 29, 2004·Transplantation·Phuong-Thu T PhamAlan H Wilkinson
May 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Hani WadeiAbdolreza Haririan
Oct 22, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Shivanand Karopadi NayakSubhramanyam V Sreepada
Mar 19, 2005·Transplant International : Official Journal of the European Society for Organ Transplantation·Habib SkhiriHenri Kreis

❮ Previous
Next ❯

Citations

Nov 22, 2013·PloS One·Sandra Müller-KrebsVedat Schwenger
Apr 8, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Stephan KoromWalter Weder
Jul 29, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Simona AlexandruJuan José Plaza
Jun 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L AlbigesP Camus
Mar 16, 2007·Expert Opinion on Emerging Drugs·Babith MankidyHarish Seethamraju
Dec 21, 2012·Expert Opinion on Drug Safety·Nicolas Pallet, Christophe Legendre
Apr 29, 2015·Expert Opinion on Drug Safety·Jost KlawitterUwe Christians
Sep 8, 2012·Expert Opinion on Drug Safety·Hallvard HoldaasAnders Åsberg
Aug 13, 2010·Expert Opinion on Drug Safety·S Allan Schaffer, Heather J Ross
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Ana I Sánchez-Fructuoso
Feb 6, 2010·Chest·Bert VandewieleAn S De Vriese
Sep 1, 2009·Transplantation Proceedings·A Rodríguez-MorenoA I Sánchez-Fructuoso
Jan 13, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James OttonPeter S Macdonald
Jun 28, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Victor ExpósitoRafael Martín-Durán
Feb 13, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Andreas ZuckermannHannah Valantine
Mar 10, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Bibhuti B DasErle H Austin
Feb 4, 2014·Transplant International : Official Journal of the European Society for Organ Transplantation·Marije C BaasFrederike J Bemelman
Apr 4, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Markus RothenburgerUNKNOWN Certican Consensus Study Group
Oct 26, 2013·Transplantation Proceedings·N FukushimaY Sawa
Jul 6, 2014·The American Journal of Emergency Medicine·Wei Li Wang, Li Xin Yu
Sep 24, 2016·Expert Opinion on Drug Metabolism & Toxicology·Gabriel Fernandes-SilvaÉrika B Rangel
Nov 19, 2011·Immunotherapy·Massimiliano VerouxPierfrancesco Veroux
Oct 14, 2006·Therapeutic Drug Monitoring·Irina BuhaescuAdrian Covic
Feb 8, 2007·Current Opinion in Cardiology·Finn Gustafsson, Heather J Ross
Jul 10, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Jelte KelchtermansJayanthi Chandar
Mar 15, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lee S NguyenJoe-Elie Salem
Jun 20, 2020·Respiratory Medicine Case Reports·Ahmed M AlkhunaiziAhmed I Alsagheir
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L AlbigesP Camus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Victor ExpósitoRafael Martín-Durán
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Sascha DavidDanilo Fliser
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Markus RothenburgerCertican Consensus Study Group
© 2022 Meta ULC. All rights reserved